$ISCO
International Stem Cell CORP

2014 Q2 Form 10-Q Financial Statement

#000156459014003361 Filed on August 08, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $1.588M $1.457M
YoY Change 8.99% 37.97%
Cost Of Revenue $409.0K $329.0K
YoY Change 24.32% 5.11%
Gross Profit $1.179M $1.128M
YoY Change 4.52% 51.82%
Gross Profit Margin 74.24% 77.42%
Selling, General & Admin $2.011M $2.344M
YoY Change -14.21% 1.78%
% of Gross Profit 170.57% 207.8%
Research & Development $1.411M $974.0K
YoY Change 44.87% 12.6%
% of Gross Profit 119.68% 86.35%
Depreciation & Amortization $101.0K $100.0K
YoY Change 1.0% -5.66%
% of Gross Profit 8.57% 8.87%
Operating Expenses $3.422M $3.318M
YoY Change 3.13% 4.73%
Operating Profit -$2.243M -$2.190M
YoY Change 2.42% -9.69%
Interest Expense $1.000K $1.000K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$2.167M -$8.000K
YoY Change 26987.5% -84.62%
Pretax Income -$4.410M -$2.200M
YoY Change 100.45% -11.18%
Income Tax
% Of Pretax Income
Net Earnings -$4.410M -$2.200M
YoY Change 100.45% -11.18%
Net Earnings / Revenue -277.71% -151.0%
Basic Earnings Per Share -$3.88
Diluted Earnings Per Share -$3.88 -$2.933M
COMMON SHARES
Basic Shares Outstanding 1.138M
Diluted Shares Outstanding 1.138M

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $750.0K $650.0K
YoY Change 15.38% -84.85%
Cash & Equivalents $748.0K $1.792M
Short-Term Investments
Other Short-Term Assets $590.0K $710.0K
YoY Change -16.9% 144.83%
Inventory $1.470M $1.370M
Prepaid Expenses
Receivables $406.0K $454.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.213M $3.191M
YoY Change 0.69% -47.34%
LONG-TERM ASSETS
Property, Plant & Equipment $847.0K $928.0K
YoY Change -8.73% -25.76%
Goodwill
YoY Change
Intangibles $2.522M $1.947M
YoY Change 29.53%
Long-Term Investments
YoY Change
Other Assets $30.00K $30.00K
YoY Change 0.0% 50.0%
Total Long-Term Assets $3.402M $2.907M
YoY Change 17.03% 2.0%
TOTAL ASSETS
Total Short-Term Assets $3.213M $3.191M
Total Long-Term Assets $3.402M $2.907M
Total Assets $6.615M $6.098M
YoY Change 8.48% -31.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $798.0K $743.0K
YoY Change 7.4% -25.7%
Accrued Expenses $960.0K $1.389M
YoY Change -30.89% 78.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.039M $2.576M
YoY Change -20.85% 15.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.039M $2.576M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.040M $2.580M
YoY Change -20.93% 15.18%
SHAREHOLDERS EQUITY
Retained Earnings -$88.12M -$75.71M
YoY Change 16.39%
Common Stock $214.0K $113.0K
YoY Change 89.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$365.0K -$1.419M
YoY Change
Total Liabilities & Shareholders Equity $6.615M $6.098M
YoY Change 8.48% -31.56%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$4.410M -$2.200M
YoY Change 100.45% -11.18%
Depreciation, Depletion And Amortization $101.0K $100.0K
YoY Change 1.0% -5.66%
Cash From Operating Activities -$1.330M -$1.040M
YoY Change 27.88% -27.27%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K -$200.0K
YoY Change 100.0% -16.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$400.0K -$200.0K
YoY Change 100.0% -13.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $550.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.480M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.330M -1.040M
Cash From Investing Activities -400.0K -200.0K
Cash From Financing Activities 1.480M 0.000
Net Change In Cash -250.0K -1.240M
YoY Change -79.84% -27.91%
FREE CASH FLOW
Cash From Operating Activities -$1.330M -$1.040M
Capital Expenditures -$400.0K -$200.0K
Free Cash Flow -$930.0K -$840.0K
YoY Change 10.71% -29.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7021000
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21000
CY2014Q2 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
dei Entity Registrant Name
EntityRegistrantName
International Stem Cell CORP
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
306000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-1758000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2039000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
406000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q2 us-gaap Inventory Net
InventoryNet
1470000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
658000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
748000
CY2013Q4 us-gaap Inventory Net
InventoryNet
1369000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
960000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
539000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2243000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1290000
CY2014Q2 isco Deposits And Other Assets
DepositsAndOtherAssets
33000
CY2013Q4 isco Deposits And Other Assets
DepositsAndOtherAssets
33000
dei Entity Central Index Key
EntityCentralIndexKey
0001355790
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
213590669
CY2014Q2 us-gaap Assets
Assets
6615000
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
31000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4410000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
4626000
dei Trading Symbol
TradingSymbol
ISCO
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-365000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-4223000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6615000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7739000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4925000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
214000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
151000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
87537000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
77897000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88116000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82271000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213590669
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151175053
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213590669
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151175053
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1588000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1457000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
532000
CY2013Q4 us-gaap Assets
Assets
7739000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
798000
us-gaap Cost Of Revenue
CostOfRevenue
663000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
974000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2369000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
3831000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2980000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1665000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2742000
CY2014Q2 us-gaap Revenues
Revenues
1588000
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3237000
CY2013Q2 us-gaap Revenues
Revenues
1457000
us-gaap Revenues
Revenues
3237000
us-gaap Revenues
Revenues
2742000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
409000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
329000
us-gaap Cost Of Revenue
CostOfRevenue
848000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1411000
CY2014Q2 us-gaap Marketing Expense
MarketingExpense
679000
us-gaap Marketing Expense
MarketingExpense
1348000
CY2014Q2 isco Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
3445000
isco Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
3445000
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
18000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
20000
us-gaap Interest Expense
InterestExpense
2000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2200000
CY2014Q2 us-gaap Interest Expense
InterestExpense
1000
us-gaap Interest Expense
InterestExpense
2000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1693000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2522000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2250000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
847000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
830000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
85000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3913000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
17000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2893000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
362000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-373000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3266000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3904000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-4410000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
231000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
341000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
234000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3289000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4410000
us-gaap Net Income Loss
NetIncomeLoss
-5845000
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Sales </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue from product sales at the time of shipment to the customer, provided no significant obligations remain and collection of the receivable is reasonably assured. If the customer has a right of return, the Company recognizes product revenues upon shipment, provided that future returns can be reasonably estimated. In the case where returns cannot be reasonably estimated, revenue will be deferred until such estimates can be made or the right of return has lapsed. LCT contributed 52% and 50% of total revenue during the six months ended June&#160;30, 2014 and 2013, respectively. LSC contributed 48% and 50% of total revenue during the six months ended June&#160;30, 2014 and 2013, respectively. </p></div>
CY2014Q2 isco Percentage Of Ownership In Issue And Outstanding Share Of Common Stock Parent Company
PercentageOfOwnershipInIssueAndOutstandingShareOfCommonStockParentCompany
0.937
isco Burn Rate Excluding Capital Expenditures And Patent Costs
BurnRateExcludingCapitalExpendituresAndPatentCosts
560000
isco Capital Expenditures And Patent Costs
CapitalExpendituresAndPatentCosts
93000
CY2004Q2 us-gaap License Costs
LicenseCosts
400000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
85000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
137000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
203000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
123000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
179000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
266000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-226000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-330000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
659000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
654000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
654000
us-gaap Interest Paid
InterestPaid
2000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
isco Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2014Q2 us-gaap Assets Current
AssetsCurrent
3213000
us-gaap Inventory Write Down
InventoryWriteDown
8000
CY2013Q2 us-gaap Marketing Expense
MarketingExpense
679000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1695000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5845000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3913000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Marketing Expense
MarketingExpense
1191000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1332000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3097000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
3647000
us-gaap Costs And Expenses
CostsAndExpenses
7545000
us-gaap Costs And Expenses
CostsAndExpenses
6646000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2243000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2190000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4308000
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1271000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1894000
us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
16000
us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
13000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2200000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5845000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Net Income Loss
NetIncomeLoss
-3913000
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2200000
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
112410000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
162108000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
108013000
CY2013 isco Common Stock Issuance Cost
CommonStockIssuanceCost
178000
CY2013Q2 us-gaap Interest Expense
InterestExpense
1000
CY2014Q2 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
8000
CY2013Q2 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
9000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
11000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
170632000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3381000
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
240000
CY2013 isco Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
2700000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-10479000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2469000
isco Stock Issued During Period Value For Warrant Exchange
StockIssuedDuringPeriodValueForWarrantExchange
6428000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
721000
isco Common Stock Issuance Cost
CommonStockIssuanceCost
169000
CY2013 isco Commissions
Commissions
98000
isco Warrant Exchange Issuance Costs
WarrantExchangeIssuanceCosts
49000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
721000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
849000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
22000
us-gaap Inventory Write Down
InventoryWriteDown
22000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-16000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
36000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
19000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-119000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
207000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
50000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
12000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-61000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
10000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3357000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
218000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-558000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2638000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
218000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2420000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1495000
us-gaap Interest Paid
InterestPaid
2000
isco Warrant Liability Reclassified To Equity Upon Warrant Exchange
WarrantLiabilityReclassifiedToEquityUponWarrantExchange
3031000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values and transactions using the Black-Scholes option pricing model, e.g., warrants and stock options, as well as the Monte-Carlo valuation method for certain warrants. Actual results could differ from those estimates. </p></div>
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2377000
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5000
CY2013Q4 isco Warrant To Purchase Common Stock
WarrantToPurchaseCommonStock
4925000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
374000
CY2013Q1 isco Warrant Term
WarrantTerm
P5Y
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassification </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts within the unaudited condensed consolidated statements of operations for the prior period have been reclassified to conform to the current period presentation. These reclassifications had no impact on the Company&#8217;s previously reported results of operations. </p></div>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Deferred Revenue and Allowance for Sales Returns </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue from product sales when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price to the buyer is fixed or determinable, and collectability is reasonably assured. However, the LSC products have a 30-day product return guarantee for website sales. The Company has estimated the historical rate of returns for the 30-day product return guarantee, which has remained consistent for the three and six months ended June 30, 2014 as compared to the years ended December&#160;31, 2013 and 2012. At June&#160;30, 2014 and December&#160;31, 2013, the estimated allowance for sales returns was $10,000. At June&#160;30, 2014 and December&#160;31, 2013, net deferred revenue totaled $0 and $3,000, respectively. </p></div>
CY2013Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.20
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2025000
CY2006Q3 isco Common Stock In Subsidiary Company
CommonStockInSubsidiaryCompany
20000000
CY2013Q4 isco Potential Common Stock Value To Be Sold
PotentialCommonStockValueToBeSold
10250000
CY2013 us-gaap Revenues
Revenues
6147000
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2013 isco Right Of Return Guarantee Period
RightOfReturnGuaranteePeriod
P30D
CY2012 isco Right Of Return Guarantee Period
RightOfReturnGuaranteePeriod
P30D
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2014Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5000
CY2014Q2 isco Warrant To Purchase Common Stock
WarrantToPurchaseCommonStock
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
20236077
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
16916733
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
7082333
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
6846560
CY2013Q4 isco Convertible Preferred Stock Conversion Price
ConvertiblePreferredStockConversionPrice
0.15
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7762500
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
9462500
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
242000
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
147000
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
497000
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
446000
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
867000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
902000
CY2014Q2 us-gaap Inventory Gross
InventoryGross
1606000
CY2013Q4 us-gaap Inventory Gross
InventoryGross
1495000
CY2014Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
136000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
126000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2582000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2364000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1735000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1534000
CY2014Q2 us-gaap Depreciation
Depreciation
101000
us-gaap Depreciation
Depreciation
202000
CY2013Q2 us-gaap Depreciation
Depreciation
100000
us-gaap Depreciation
Depreciation
201000
CY2003Q4 us-gaap License Costs
LicenseCosts
340000
CY2004Q1 us-gaap License Costs
LicenseCosts
22500
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2273000
CY2014Q2 us-gaap License Costs
LicenseCosts
3020000
CY2013Q4 us-gaap License Costs
LicenseCosts
2760000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16000
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
542000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
510000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
31000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
62000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
62000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
62000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
62000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2200000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2479000
CY2008Q2 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2008Q2 isco Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
250000
CY2014Q2 isco Revenue Realized From Agreement
RevenueRealizedFromAgreement
0
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2008Q2 isco Number Of Accredited Investors
NumberOfAccreditedInvestors
5
CY2013Q1 isco Convertible Preferred Stock Conversion Price
ConvertiblePreferredStockConversionPrice
0.20
isco Convertible Preferred Stock Conversion Price
ConvertiblePreferredStockConversionPrice
0.0667
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10125000
CY2013Q1 isco Common Stock Warrants Issued To Purchase Common Stock Percentage
CommonStockWarrantsIssuedToPurchaseCommonStockPercentage
0.50
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5062500
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.20
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5000000
CY2013Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.20
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000000
CY2013Q1 isco Common Stock Warrants Issued To Purchase Common Stock Percentage
CommonStockWarrantsIssuedToPurchaseCommonStockPercentage
0.50
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2500000
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.20
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 isco Percentage Of Gross Proceeds Paid To Agent
PercentageOfGrossProceedsPaidToAgent
0.05
CY2013Q3 isco Agents Fees Percentage On Gross Proceeds
AgentsFeesPercentageOnGrossProceeds
0.05
CY2013 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2013-10-24
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.15
isco Related Party Rent Expense
RelatedPartyRentExpense
81000
isco Related Party Rent Expense
RelatedPartyRentExpense
79000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
440000
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1562000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M11D
CY2013Q1 isco Warrant Term
WarrantTerm
P5Y
CY2013Q4 us-gaap Share Price
SharePrice
0.21
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.15
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.843
CY2013Q3 isco Fair Value Of Warrant Liabilities In Excess Of Proceeds
FairValueOfWarrantLiabilitiesInExcessOfProceeds
1390000
CY2013Q3 isco Warrant Liabilities
WarrantLiabilities
4485000
CY2013Q4 isco Warrant Liabilities
WarrantLiabilities
4925000
CY2014Q2 isco Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants
CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants
0
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.25
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3500000
CY2013 isco Warrant Issued
WarrantIssued
64983988
CY2013Q4 isco Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants
CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants
37888154
CY2014Q1 isco Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants
CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants
37888154
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3333333
CY2014Q2 isco Stock Issued During Period New Issues Value Per Share
StockIssuedDuringPeriodNewIssuesValuePerShare
0.15
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5500000
CY2014Q2 isco Stock Issued During Period New Issues Value Per Share
StockIssuedDuringPeriodNewIssuesValuePerShare
0.10
CY2014Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
550000
CY2014Q2 isco Stock Issued During Period Shares For Warrant Exchange
StockIssuedDuringPeriodSharesForWarrantExchange
44665783
CY2014Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
132111479
CY2014Q2 isco Related Party Rent Expense
RelatedPartyRentExpense
41000
CY2013Q2 isco Related Party Rent Expense
RelatedPartyRentExpense
45000
CY2013 isco Warrant Exercised
WarrantExercised
16954822
CY2013 isco Warrant Forfeited Or Cancelled
WarrantForfeitedOrCancelled
6545178
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
44983988
isco Warrant Issued
WarrantIssued
isco Warrant Exchanged
WarrantExchanged
37221488
isco Warrant Exercised
WarrantExercised
isco Warrant Forfeited Or Cancelled
WarrantForfeitedOrCancelled
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7762500
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
79000
CY2013Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
84000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
158000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
158000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
194000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
397000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
101000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
695000
isco Number Of Products
NumberOfProducts
130

Files In Submission

Name View Source Status
0001564590-14-003361-index-headers.html Edgar Link pending
0001564590-14-003361-index.html Edgar Link pending
0001564590-14-003361.txt Edgar Link pending
0001564590-14-003361-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isco-10q_20140630.htm Edgar Link pending
isco-20140630.xml Edgar Link completed
isco-20140630.xsd Edgar Link pending
isco-20140630_cal.xml Edgar Link unprocessable
isco-20140630_def.xml Edgar Link unprocessable
isco-20140630_lab.xml Edgar Link unprocessable
isco-20140630_pre.xml Edgar Link unprocessable
isco-ex311_20140630342.htm Edgar Link pending
isco-ex312_20140630343.htm Edgar Link pending
isco-ex321_20140630344.htm Edgar Link pending
isco-ex322_20140630345.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending